Todd Davis

Insider profile

Currently holds positions in Ligand Pharmaceuticals Incorporated, BioDelivery Sciences International Inc and Vaxart Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
10 70% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Ligand Pharmaceuticals Incorporated March 1, 2007 -
Independent Director BioDelivery Sciences International Inc May 17, 2018 -
Independent Director Vaxart Inc Oct. 25, 2019 -
Todd Davis's trades of Pelthos Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vaxart Inc (VXRT)
Transaction date
Sale
Price
3.28
Quantity 60,000 -33.3%
Value US$196,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-11
B Purchase
95,899 -3.3%
396.68
US$2,369,562 		95,899 -3.3% 396.68 US$2,369,562
2026-06-15 2026-06-11
B Purchase
94,332 -46.3%
475.96
US$1,959,402 		94,332 -46.3% 475.96 US$1,959,402
2025-05-13 2025-05-09
B Purchase
24,854 +49.5%
390.83
US$2,826,985 		24,854 +49.5% 390.83 US$2,826,985
2025-05-13 2025-05-09
B Purchase
2,307 +1.5%
104.53
US$241,150 		2,307 +1.5% 104.53 US$241,150
2025-05-13 2025-05-09
B Purchase
1,680 +1.1%
104.57
US$175,678 		1,680 +1.1% 104.57 US$175,678
2024-08-09 2024-08-08
B Purchase
2,500 +2.1%
97.39
US$243,480 		2,500 +2.1% 97.39 US$243,480
2023-09-25 2023-09-22
B Purchase
4,000 +5.8%
59.38
US$237,529 		4,000 +5.8% 59.38 US$237,529
2021-02-12 2021-02-10
S Sale
5,083 -9.6%
213.14
US$1,083,410 		5,083 -9.6% 213.14 US$1,083,410
2020-08-20 2020-08-18
S Sale
50,000 -18.7%
4.99
US$249,500 		50,000 -18.7% 4.99 US$249,500
2020-04-30 2020-04-28
US Vaxart Inc (VXRT)
S Sale
60,000 -33.3%
3.28
US$196,500 		60,000 -33.3% 3.28 US$196,500